Heron Therapeutics, Inc. (HRTX Quick QuoteHRTX - Free Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now down 6.1% in the past one-month time frame.

The company has seen two positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Heron Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Heron Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Investors interested in the Medical - Drugs industry may consider a better-ranked stock like Pacira Pharmaceuticals, Inc. (PCRX Quick QuotePCRX - Free Report) , which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
   
Is HRTX going up? Or down? Predict to see what others think:Up or Down

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.6% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>